New research moves novel gene therapy for heart failure closer to the clinic
Knocking down the Hippo signaling pathway in pig cardiomyocytes after a heart attack, resulted in heart tissue renewal and improved function.
Read MoreKnocking down the Hippo signaling pathway in pig cardiomyocytes after a heart attack, resulted in heart tissue renewal and improved function.
Read MoreMore than 30 million people in the United States alone are affected by osteoarthritis (OA), a degenerative joint disease, and that number is expected to
Read MoreFrancis Collins, NIH Director, and Scott Gottlieb, FDA Commissioner, recently announced plans to eliminate oversight of new gene therapy experiments by the NIH’s Recombinant DNA
Read MoreOsteoarthritis is a multifactorial degenerative joint disorder that poses a major challenge for treatment. This condition currently affects 28 million people in the United States
Read MoreOn April 1, 2016, the European Medicines Agency (EMA) approved the first ex-vivo (outside the body) gene therapy in the Western Hemisphere. Diseased stem cells
Read More